Morphologic brain network predicts levodopa responsiveness in Parkinson disease

Morphologic brain network predicts levodopa responsiveness in Parkinson disease
Front Aging Neurosci. 2023 Jan 5;14:990913. doi: 10.3389/fnagi.2022.990913. eCollection 2022.ABSTRACTBACKGROUND: The levodopa challenge test (LCT) has been routinely used in Parkinson disease (PD) evaluation and predicts the outcome of deep brain stimulation (DBS). Guidelines recommend that patients with an improvement in Unified Parkinson's Disease Rating Scale (UPDRS)-III score > 33% in the LCT receive DBS treatment. However, LCT results are ... read more
Source: PubMedPublished on 2023-01-23By Yongsheng Xie